Three of the viruses — flu, COVID-19 and RSV — are respiratory viruses and spread from person to person through germ-filled ...

Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...

A study found that around 4 months after vaccination, people who received the RSV vaccine had a 79% reduction in their risk ...

Moderna (MRNA) announced that the Medicines and Healthcare products Regulatory Agency in the UK has granted marketing authorization for mRESVIA, indicated for active immunization for the prevention of ...

What should you know about RSV and who can get it? In many cases, there is a difference for adults and children, ...

Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.

The shot, also known as the mRESVIA is used for preventing the lower respiratory tract disease in older adults. As per the ...

"The MHRA's authorization of our RSV vaccine is an important milestone for Moderna's efforts toward respiratory disease preparedness," said Stéphane Bancel, Chief Executive Officer of Moderna. "Our ...

Advancements in prevention strategies against respiratory syncytial virus (RSV) are transforming pediatric care. Experts recommend the use of prophylactic monoclonal antibodies for immunizing infants.

UPMC Children’s Community Pediatrics is seeing an increase in cases of strep throat. They say the flu is still being ...

The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively ...

Among the viruses circulating most are COVID-19, flu and RSV. So far this season, the CDC estimates, there have been at least 24 million flu illnesses, 310,000 hospitalizations and 13,000 deaths ...